Clusterin protects neurons against intracellular proteotoxicity

Acta Neuropathol Commun. 2017 Nov 7;5(1):81. doi: 10.1186/s40478-017-0481-1.

Abstract

It is now widely accepted in the field that the normally secreted chaperone clusterin is redirected to the cytosol during endoplasmic reticulum (ER) stress, although the physiological function(s) of this physical relocation remain unknown. We have examined in this study whether or not increased expression of clusterin is able to protect neuronal cells against intracellular protein aggregation and cytotoxicity, characteristics that are strongly implicated in a range of neurodegenerative diseases. We used the amyotrophic lateral sclerosis-associated protein TDP-43 as a primary model to investigate the effects of clusterin on protein aggregation and neurotoxicity in complementary in vitro, neuronal cell and Drosophila systems. We have shown that clusterin directly interacts with TDP-43 in vitro and potently inhibits its aggregation, and observed that in ER stressed neuronal cells, clusterin co-localized with TDP-43 and specifically reduced the numbers of cytoplasmic inclusions. We further showed that the expression of TDP-43 in transgenic Drosophila neurons induced ER stress and that co-expression of clusterin resulted in a dramatic clearance of mislocalized TDP-43 from motor neuron axons, partially rescued locomotor activity and significantly extended lifespan. We also showed that in Drosophila photoreceptor cells, clusterin co-expression gave ER stress-dependent protection against proteotoxicity arising from both Huntingtin-Q128 and mutant (R406W) human tau. We therefore conclude that increased expression of clusterin can provide an important defense against intracellular proteotoxicity under conditions that mimic specific features of neurodegenerative disease.

Keywords: Chaperone translocation; Cytoplasmic inclusions; Proteotoxicity; TDP-43.

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Cell Line, Tumor
  • Clusterin / genetics
  • Clusterin / metabolism*
  • Clusterin / pharmacology*
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drosophila
  • Drosophila Proteins / genetics
  • Drosophila Proteins / metabolism
  • Endoplasmic Reticulum Stress / genetics
  • Eye / metabolism
  • Eye / ultrastructure
  • Hemolymph / cytology
  • Humans
  • Intracellular Fluid / drug effects
  • Intracellular Fluid / metabolism
  • Larva
  • Motor Activity / genetics
  • Motor Activity / physiology
  • Motor Neurons / drug effects*
  • Motor Neurons / metabolism*
  • Motor Neurons / ultrastructure
  • Neuroblastoma / pathology
  • Neurotoxicity Syndromes / drug therapy*
  • Neurotoxicity Syndromes / genetics
  • Neurotoxicity Syndromes / pathology
  • Protein Aggregates / drug effects
  • Protein Aggregates / genetics
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transfection

Substances

  • Clusterin
  • DNA-Binding Proteins
  • Drosophila Proteins
  • GAL4 protein, Drosophila
  • Protein Aggregates
  • TARDBP protein, human
  • Transcription Factors